BC
BMY icon

Brookfield Corp’s Bristol-Myers Squibb BMY Stock Holding History

Brookfield Corp’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,603
Closed -$1.19M – 173
2023
Q2 		$1.19M Buy
18,603
+8,987
+93% +$603K ﹤0.01% 454
2023
Q1 		$666K Buy
+9,616
New +$678K ﹤0.01% 553
2022
Q3 		– Sell
-199,994
Closed -$15.4M – 643
2022
Q2 		$15.4M Buy
199,994
+153,715
+332% +$11.7M 0.07% 106
2022
Q1 		$3.38M Buy
+46,279
New +$3.11M 0.01% 324
2021
Q3 		– Sell
-50,996
Closed -$3.41M – 531
2021
Q2 		$3.41M Buy
+50,996
New +$3.33M 0.02% 274

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM